AGP Executive Report
Last update: 10 hours agoCancer Treatment: The EU medicines committee recommended RASONQUE (daraxonrasib) for adults with metastatic pancreatic cancer after prior treatment. The recommendation followed a trial reporting a 60% lower risk of death than chemotherapy; European Commission approval is still pending. Women’s Health: The EU approved Kimberly-Clark’s purchase of Kenvue after requiring the sale of its feminine hygiene brands across the European Economic Area, including Liechtenstein, to preserve competition and consumer choice. Food Safety: An investigation into fishmeal preservatives traces concerns about ethoxyquin, banned in the EU, and raises questions about BHA, an alternative now under review by US regulators. Health Funding: Hungary is set to receive €254 million through Norway Grants, with some funding intended for healthcare. Liechtenstein is among the EEA countries supporting the grants.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
